Table 3.
Discharge and follow-up characteristics of infants admitted with supraventricular tachycardia
| Variable | All patients (N = 131) | By center |
P value | |
|---|---|---|---|---|
| NOTEP (n = 72) | TEPS (n = 59) | |||
| Discharge medication | ||||
| Beta-blocker | 97 (74) | 43 (60) | 54 (92) | <.001∗ |
| Digoxin | 9 (6.9) | 7 (9.7) | 2 (3.4) | .3 |
| Flecainide | 47 (36) | 15 (21) | 32 (54) | <.001∗ |
| Amiodarone | 11 (8.4) | 10 (14) | 1 (1.7) | .029∗ |
| Propafenone | 1 (0.8) | 1 (1.4) | 0 (0) | >.9 |
| No medication | 2 (1.5) | 2 (2.8) | 0 (0) | .6 |
| Discharge on multiple medications | 35 (27) | 5 (6.9) | 30 (51) | <.001∗ |
| Readmission within 31 d | 18 (13.8) | 17 (23.6) | 1 (1.7) | <.001∗ |
| Length of follow-up, d | 667 (346–1562) | 942 (502–1728) | 368 (246–785) | <.001∗ |
| Medications discontinued by study end | 112 (88) | 61 (87) | 51 (88) | >.9 |
| Age medications discontinued, mo | 12.0 (7.8–12.0) | 11.0 (8.0–13.0) | 12.0 (7.0–12.0) | .5 |
| Recurrence after medications discontinued | 10 (8.9) | 7 (11) | 3 (5.9) | .5 |
| Age of recurrence after medications discontinued, mo | 38.5 (10.0–49.0) | 36.0 (10.5–42.0) | 60.0 (34.5–78.0) | .3 |
| Patient underwent ablation | 7 (5.4) | 6 (8.3) | 1 (1.7) | .2 |
Values are n (%) or median (interquartile range).
NOTEP = no transesophageal pacing; TEPS = transesophageal pacing studies.
∗
P-values < .05.